US/UK/Canada

Share

Pick a time period -
Tags ( Active)

NorthShore University HealthSystem Announces First of its Kind Clinical Trial to Examine Use of Predictive Genetic Tests for Cancer Risk Assessment

Trial to examine impact of genetic risk score testing on screening for breast, prostate and colorectal cancerResearchers at NorthShore University HealthSystem  (NorthShore) have launched the first clinical trial to investigate a genetic risk score (GRS) test to predict the risk of breast, prostate and colorectal cancer in the primary care setting. The test was developed by NorthShore researcher Jianfeng Xu, DrPH, in order to provide primary care physicians with a tool to better understand how to prevent and treat cancer, and learn how patients respond after

NorthShore University HealthSystem to Participate in Largest Research Project in U.S. History

NIH Awards $2.3 million to NorthShore for five-year studyAs a member of the Illinois Precision Medicine Consortium (IPMC) – a component of the White House’s Precision Medicine Initiative (PMI) – NorthShore University HealthSystem (NorthShore)  will be awarded $2.3 million from the National Institutes of Health (NIH) to enroll 9,000 NorthShore patients into this unprecedented, nationwide genomic research initiative. The IPMC is part of a wider $55 million federal set of awards under the PMI in support of reaching the goal of enrolling 1 million people to improve

NorthShore University HealthSystem Provides Roadmap to Quality Improvement and Practice-Based Research Using EMR

September 24, 2015 – NorthShore University HealthSystem (NorthShore) clinicians have identified ways to utilize data captured by its Electronic Medical Record (EMR) to identify eligible clinical trial patients, assign treatments, and measure outcomes at the point of care. A step-by-step description of NorthShore’s quality journey will be posted online September 24 and will publish in the October issue of Neurology Clinical Practice, a medical journal of the American Academy of Neurology. “The work we’ve done provides a roadmap for how other neurology practice groups can follow a similar

NorthShore is First in Chicagoland area offering New Technology to Reach Brain Tumors Previously Deemed ‘Inoperable’

NorthShore is one of only three sites in Illinois offering this technologyHaving a full throttle life professionally and with her three children, 44-year old Jill Vannatta has a new normal as she recuperates from brain surgery. A mass five inches deep into the thalamus portion of her brain was successfully removed through an opening smaller than a dime. An avid hunter jumper, she was in Florida participating in a horse show when the mass was discovered. She flew home for surgery performed by Julian Bailes, MD, at NorthShore University HealthSystem 

Complexities of Genetics of Parkinson’s Disease Continue to Surprise Researchers

NorthShore Researcher Relentless in Pursuit of AdvancementsFebruary 27, 2014 – A study led by Demetrius Maraganore, MD, Chairman of the Department of Neurology, NorthShore University HealthSystem was recently published in the journal Movement Disorders . This large, longitudinal study involving more than 21 centers and 6,000 patients from all over the world is the first ever to examine the association of genetic variations with survival in Parkinson’s disease. An estimated 1 million people in the United States and more

NorthShore University HealthSystem Study Finds Physicians Often Use Inexact Data When Deciding to Prescribe Antibiotics

Evanston, Ill. – August 6, 2012 – The over-use of antibiotics is a major public health concern, and a new study by NorthShore University HealthSystem (NorthShore) found that physicians often rely on imprecise information when deciding whether or not to prescribe antibiotics. The study, published in the August 7, 2012, issue of the Annals of Internal Medicine , also suggests that the increasing use of electronic health records (EHRs) by hospitals and health systems provides a goldmine of data that, when analyzed properly, can supply physicians more exact, real-time

NorthShore University HealthSystem First in Illinois to Use Innovative Technology to Recognize Potential for Alzheimer’s Disease in Patients

Scan identifies a marker of cognitive decline by looking at brain plaque content, which previously could only be evaluated in deceasedEvanston, IL – June 28, 2012 – NorthShore University HealthSystem  (NorthShore) is the first health system in the state of Illinois to evaluate patients for Alzheimer’s Disease (AD) utilizing Amyvid (Florbetapir F 18 Injection) -- the first and only radioactive diagnostic agent approved for Positron Emission Tomography (PET) imaging of plaques in the living brain (approved by the FDA in April 2012). The drug is being used to

NorthShore University HealthSystem Researcher Leads International Collaboration to Find Five New Genetic Loci Associated with Schizophrenia

Evanston, IL – September 21, 2011 – Pablo V. Gejman, M.D., Director of the NorthShore University HealthSystem (NorthShore) Center for Psychiatric Genetics led an international consortium conducting a genome-wide association study (GWAS) on schizophrenia. The researchers found five novel genetic variants that increase the susceptibility to schizophrenia. The findings are reported in the September 18, 2011 advance online edition of the journal Nature Genetics . Schizophrenia is an elusive and severe psychiatric disorder that

There are no items matching the current filter
There are no more items matching the current filter
Back to top